ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,828.00
      0.95%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      86.775
      0.00%
      Bitcoin
      58,198.09
      -0.18%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Palisade Bio Inc (PALI)

      7. Palisade Bio Inc (PALI) News

      PALI

      Palisade Bio (PALI)

      Palisade Bio Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:PALI
      DateTimeSourceHeadlineSymbolCompany
      02/22/20225:55PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PALIPalisade Bio Inc
      02/18/20228:30AMGlobeNewswire Inc.Palisade Bio (Nasdaq: PALI) to Present at the Biocom Global Life Science Partnering ConferenceNASDAQ:PALIPalisade Bio Inc
      02/15/20228:30AMGlobeNewswire Inc.Palisade Bio (NASDAQ: PALI) Adds Pharmaceutical Industry Executive Robert McRae to Leadership TeamNASDAQ:PALIPalisade Bio Inc
      02/14/20223:10PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PALIPalisade Bio Inc
      02/14/20222:47PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PALIPalisade Bio Inc
      02/11/20227:45AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PALIPalisade Bio Inc
      02/10/20226:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PALIPalisade Bio Inc
      02/10/20226:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PALIPalisade Bio Inc
      02/10/20226:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PALIPalisade Bio Inc
      02/10/20226:26PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PALIPalisade Bio Inc
      02/10/20226:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PALIPalisade Bio Inc
      02/10/20226:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PALIPalisade Bio Inc
      02/10/20226:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PALIPalisade Bio Inc
      02/10/20226:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PALIPalisade Bio Inc
      02/10/20226:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PALIPalisade Bio Inc
      02/08/20228:00AMGlobeNewswire Inc.Palisade Bio (Nasdaq: PALI) to Announce Adhesions Clinical Data at SAGES 2022 Annual MeetingNASDAQ:PALIPalisade Bio Inc
      12/29/20218:30AMGlobeNewswire Inc.Palisade Bio to Present at the H.C. Wainwright BIOCONNECT Virtual Conference and Biotech ShowcaseNASDAQ:PALIPalisade Bio Inc
      12/09/20216:04AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PALIPalisade Bio Inc
      12/08/20218:00AMGlobeNewswire Inc.Palisade Bio Granted New U.S. Patent Covering Protease Inhibitor LB1148 for Treating Adhesions and Postoperative IleusNASDAQ:PALIPalisade Bio Inc
      11/30/20218:00AMGlobeNewswire Inc.Palisade Bio Announces the European Patent Office to Grant a Patent for its Lead Drug Candidate LB1148, Providing Protection Through 2035NASDAQ:PALIPalisade Bio Inc
      11/23/20218:00AMGlobeNewswire Inc.Palisade Bio Announces Inducement Awards Under Inducement Plan for Key New Hires, Including Nick McCoy, Vice President of Clinical OperationsNASDAQ:PALIPalisade Bio Inc
      11/15/20217:00AMGlobeNewswire Inc.Palisade Bio Reports Third Quarter Financial ResultsNASDAQ:PALIPalisade Bio Inc
      11/12/20215:22PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PALIPalisade Bio Inc
      10/28/20219:03AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PALIPalisade Bio Inc
      10/22/20219:51AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PALIPalisade Bio Inc
      10/22/20218:00AMGlobeNewswire Inc.Palisade Bio, Inc. Announces Sale of Seneca Asset NSI-189 for the Treatment of Central Nervous System DisordersNASDAQ:PALIPalisade Bio Inc
      10/07/20213:56PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:PALIPalisade Bio Inc
      09/23/20214:24PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:PALIPalisade Bio Inc
      09/22/20217:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PALIPalisade Bio Inc
      09/22/20217:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PALIPalisade Bio Inc
       Showing the most relevant articles for your search:NASDAQ:PALI